Common warning symptoms include: One-sided leg swelling, pain, tenderness, warmth, or unusual redness consistent with DVT Sudden shortness of breath, sudden difficulty breathing, or rapid breathing may signal pulmonary embolism Sharp chest pain that worsens with deep breaths, cough, or movement Rapid heart rate, lightheadedness, fainting, or collapse Sudden numbness or weakness on one side of the body, trouble speaking, or vision changes that could indicate stroke or TIA Severe abdominal pain out of proportion to the exam that could suggest mesenteric ischemia Any of these symptoms requires immediate medical evaluation
Our ongoing clinical care provides a higher standard of care that truly transforms lives. Specific combinations of therapies can enhance your wellness goals, and a Restore Membership is the best way to get deals and achieve the consistency you need to feel and look your best
These results suggest the triple-agonist approach can outperform single-hormone GLP-1 drugs, and even dual GLP-1/GIP agents in some analyses
On average, patients who took 12 mg doses lost 11.5 lbs, or 5.8% of their body weight, while patients who were administered 36 mg doses lost 15.8 lbs, or 7.6% of their body weight
The SURMOUNT-5 trial was designed to provide a head-to-head comparison and its data should be interpreted carefully when published
Long-term storage planning for multi-month protocols Semaglutide protocols typically span months
